Mylan

12 Stories

New EpiPen Competitor Approved by FDA

Generic alternative should hit the market soon

(Newser) - Parents of children with serious allergies may soon get some relief when shelling out for a epinephrine auto-injector. The FDA has approved a generic alternative to Mylan Pharmaceuticals' widely used EpiPen and EpiPen Jr., reports CNN . While other name-brand injectors exist, this one, produced by Teva, is the first approved...

Company Rolls Out Cheaper Version of EpiPen

It will still cost $300 per pack of 2

(Newser) - Mylan is releasing a generic version of its emergency allergy treatment EpiPen at half the price of the branded option, the cost of which drew scorn from parents nationwide and spawned Congressional inquiries. The potential cost savings will depend in part on a patient's insurance coverage and qualifications for...

Mylan's Measly $100 EpiPen Profit? It's Really $160

Pharma company offers what the WSJ calls 'clarification'

(Newser) - If you thought it seemed just a bit bananas that Mylan makes only $100 profit per EpiPen two-pack, which it sells for $608, you weren't alone. CEO Heather Bresch testified to that fact in front of the House Government Oversight Committee last Wednesday, as one disbelieving congressman flat-out asked,...

CEO: Mylan Only Makes $50 Profit Per EpiPen

Heather Bresch testifies before Congress

(Newser) - Outraged Republican and Democratic lawmakers on Wednesday grilled the head of pharmaceutical company Mylan about the significant cost increase of its life-saving EpiPens and the profits for a company with sales in excess of $11 billion, the AP reports. Mylan CEO Heather Bresch held up an EpiPen as she told...

Mylan Caves a Bit More With Generic EpiPen

2-pack will list for $300

(Newser) - Relief is coming: In what Bloomberg notes is Mylan's second move after an explosion of criticism over the price of its EpiPens, the company on Monday announced it will start selling a cheaper version. The drugmaker says it will make available in the next several weeks a generic EpiPen...

As EpiPen Controversy Erupted, CEO Unloaded $5M in Stock

Heather Bresch sold 100K shares in deal meant to thwart appearance of insider trading

(Newser) - Mylan CEO Heather Bresch has taken her fair share of scrutiny lately over EpiPen's soaring price , her own soaring salary , her dad , and even a since-rescinded MBA from West Virginia University. But even as her company's controversy grew, Bresch did something else that's getting scrutinized: She unloaded...

EpiPen Company CEO: I'm No Martin Shkreli

Mylan's Heather Bresch defends the EpiPen's high prices, her own style to 'NYT'

(Newser) - Is Mylan CEO Heather Bresch the next Martin Shkreli? Based on public reaction to the bloated costs of her company's EpiPen, the 671% pay raise she's reaped as those costs rose, and the recently publicized fact that her dad is a US Senator , the initial answer may seem...

Sarah Jessica Parker to EpiPen Maker: I'm Out

Actress won't be spokeswoman anymore for Mylan because of steep price increases

(Newser) - As lawmakers deal with their own awkward situation related to the jacked-up costs of the EpiPen , a celebrity is taking her own stand. Sarah Jessica Parker—who Gizmodo notes has campaigned for anaphylaxis awareness for manufacturer Mylan in the name of her son, who has a severe peanut allergy—announced...

Drug CEO's Dad in Senate Now a Big Focus
Raising Eyebrows: EpiPen
CEO's Dad Is a Senator
the rundown
Aug 25, 2016 11:03 AM CDT

Raising Eyebrows: EpiPen CEO's Dad Is a Senator

Mylan's Heather Bresch is the daughter of Sen. Joe Manchin

(Newser) - Prior to the recent outrage at drugmaker Mylan for jacking the price of EpiPens into the stratosphere, it wasn't widely known that company CEO Heather Bresch, 47, was the daughter of Democratic Sen. Joe Manchin of West Virginia. That has changed in a big way, with major media outlets...

EpiPen Just Got Cheaper for Some
EpiPen Just Got
Cheaper for Some
Aug 25, 2016 7:54 AM CDT

EpiPen Just Got Cheaper for Some

Caving to pressure, Mylan expands assistance programs

(Newser) - The public scolding of drugmaker Mylan over the soaring price of EpiPen seems to have worked: The company on Thursday didn't lower the price, but it made the allergy injections cheaper for many by expanding its assistance programs. Specifically, it doubled eligibility for relief to 400% of the poverty...

There's a Cheaper 'EpiPen,' but There's a Catch

Most people aren't trained on more-affordable Adrenaclick, which could lead to injuries

(Newser) - Not since Martin Shkreli has there been such outrage over the spiking costs of a life-saving device or drug. Mylan, the maker of the EpiPen, has bumped up costs by almost 500% over the past few years, and because the drugmaker enjoys a near-monopoly on the epinephrine-delivering device—the AP...

Rise in Food Allergies Means Big Business for EpiPen

Mylan lobbies to relax prescription rules for epinephrine injections

(Newser) - With severe food allergies on the rise in the United States, anaphylactic reactions are an increasing problem, especially at schools. But, in most states, school nurses risk losing their license if they give an epinephrine injection to a student who does not have a prescription—even though up to a...

12 Stories
Most Read on Newser